Stocks and Investing Stocks and Investing
Wed, February 28, 2024

Andrew Fein Reiterated (ZNTL) at Strong Buy and Held Target at $46 on, Feb 28th, 2024


Published on 2024-10-28 09:15:24 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Reiterated "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy and Held Target at $46 on, Feb 28th, 2024.

Andrew has made no other calls on ZNTL in the last 4 months.



There are 2 other peers that have a rating on ZNTL. Out of the 2 peers that are also analyzing ZNTL, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • Bradley Canino of "Stifel" Maintained at Strong Buy with Decreased Target to $36 on, Tuesday, November 7th, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $38 on, Tuesday, November 7th, 2023
Contributing Sources